Clinical Trial 54652

Berlin, NJ 08009


A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study of Buntanetap in Participants with Mild to Moderate Alzheimer’s Disease 

Qualified Participants Must:

• Be 55 and 85 years old
• Be diagnosed with mild to moderate Alzheimer's disease
• Additional criteria apply

Qualified Participants May Receive:

Up to $750 for time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.